Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils

NCT04538937 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT04538937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04538937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils
Lead sponsor
Medical University Innsbruck
Phase
Observational
Overall status
Recruiting
Start date
February 26, 2020
Completion date
February 26, 2030
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

egpa - eosinophilic granulomatosis with polyangiitis, eosinophilic asthma, eosinophilic pneumonia, hes - hypereosinophilic syndrome, samter triad